• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Evan S. Kantor, BS

Latest:

Cost of Post-Traumatic Stress Disorder vs Major Depressive Disorder Among Patients Covered by Medicaid or Private Insurance

Post-traumatic stress disorder was associated with 4.2% to 9.3% higher annual per-patient healthcare costs compared with MDD among patients covered by Medicaid or private insurance.






Emily D. Ehrlich, MPH

Latest:

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

The authors found no consistent pattern in the concordance between CER evidence and subsequent utilization patterns.


William Boulding, PhD

Latest:

Relationship Between Patient Satisfaction With Inpatient Care and Hospital Readmission Within 30 Days

Higher overall patient satisfaction with inpatient care and discharge planning is associated with lower 30-day readmission rates after adjusting for clinical quality.



Jerome J. Schentag, PharmD

Latest:

Costs of Treating Lower Respiratory Tract Infections

Compared with other costs of treatment, expenditures for antibiotics were nominal in an adult primary care population with lower respiratory tract infections.


Robert S. Sandler, MD, MPH

Latest:

Variability in Resource Use: Diagnosing Colorectal Cancer

In a cohort of 449 patients with colorectal cancer in the VA health system, diagnostic resource use varied with facility, patient age, and patient presentation.



Ralph McDade, PhD

Latest:

Evidence for the Benefit of Targeted Proteomics in the Era of the "Big Data" Approach

The availability of a novel predictive biomarker in diabetes care could have benefits for patients, payers, and pharma.


Bong-Chul Chu, PhD

Latest:

Comparison Between Guideline-Preferred and Nonpreferred First-Line HIV Antiretroviral Therapy

Initiation of guideline-preferred first-line antiretroviral therapy (ART) was associated with better ART adherence and persistence and similar total healthcare expenditures among Medicaid-insured HIV patients.


Pei-Tseng Kung, ScD

Latest:

Patients With Diabetes in Pay-for-Performance Programs Have Better Physician Continuity of Care and Survival

Patients with diabetes who participate in a pay-for-performance program had higher continuity of care index (COCI) scores, and those with high COCI scores had higher survival rates.


Marsha C. Moore, MD, MBA

Latest:

Prescriber Compliance With Black Box Warnings in Older Adult Patients

Elderly patients prescribed drugs with a drug-laboratory black box warning (BBW) had lower rates of prescriber BBW compliance than patients prescribed drugs with a drug-disease warning.



Joachim Szecsenyi, MD, MSc

Latest:

Primary Care Physicians' Experiences With Case Finding for Practice-Based Care Management

Criteria used by primary care physicians to select patients for practice-based care management programs were explored in a qualitative study.



Soyal R. Momin, MS, MBA

Latest:

Distal Upper and Lower Limb Fractures Associated With Thiazolidinedione Use

This study demonstrates that patients with diabetes taking thiazolidinediones have higher proportions of distal upper and lower limb fractures than those not taking the drug.


Seth W. Glickman, MD, MBA

Latest:

The Mis-Measure of Physician Performance

We discuss our concerns about tying physician performance to CG-CAHPS scores and suggest an alternative approach to facilitate translation of service excellence into clinical practice.







Karen K. Maylor, RN

Latest:

No Time to Waste: Decreasing Patient Wait Times for Chemotherapy Administration Using Automated Prioritization in an Oncology Pharmacy System

Using a prioritization algorithm in an oncology pharmacy system at the Johns Hopkins University, patient wait times for chemotherapy administration were significantly decreased.


Dan Berlowitz, MD, MPH

Latest:

Anticoagulation in Atrial Fibrillation: Impact of Mental Illness

Atrial fibrillation patients with mental health conditions are less likely to be eligible for warfarin receipt, and those who are eligible receive warfarin at lower rates.




Michael Sherman, MD

Latest:

Cost Burden of Hepatitis C Virus Treatment in Commercially Insured Patients

Rates of hepatitis C virus (HCV) treatment in a commercially insured population doubled after availability of new direct-acting antivirals. Member out-of-pocket spending was kept low while the health plan bore 99% of spending on HCV medications.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.